Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature

References

• Korff MV, Walker RL, Saunders K, Shortreed SM, Thakral M, Parchman M, Hansen RN, Ludman E, Sherman KJ, Dublin S. Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. Int J Drug Policy. 2017;46:90–98. doi:10.1016/j.drugpo.2017.05.053.
   PubMed Web of Science ®Google Scholar
• CDC/NCHS, National Vital Statistics System, Mortality. CDC WONDER, Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://wonder.cdc.gov.
   Google Scholar
• Florence CS, Zhou C, Luo F, Xu L. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Med Care. 2016;54(10):901–906. doi:10.1097/MLR.0000000000000625.
   PubMed Web of Science ®Google Scholar
• Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–190. doi:10.1001/jama.2008.976.
   PubMed Web of Science ®Google Scholar
• Koob GF, Volkow ND. Neurobiology of addiction: A neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773. doi:10.1016/S-0366(16)00104-8.
   PubMed Web of Science ®Google Scholar
• CDC. Prescription opioid overdose data. 2016c. [October 28, 2019]. https://www​.cdc.gov/drugoverdose​/data/overdose.html.
   Google Scholar
• Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths – United States, 2013-2017. WR Morb Mortal Wkly Rep. ePub: 21 December 2018;67:1419–1427.
   PubMed Web of Science ®Google Scholar
• Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6(1):11–16. doi:10.1177/2049463712438493.
   PubMedGoogle Scholar
• Stoicea N, Costa A, Periel L, Uribe A, Weaver T, Bergese SD. Current perspectives on the opioid crisis in the US healthcare system. Medicine. 2019;98(20):e15425. doi:10.1097/MD.0000000000015425.
   PubMed Web of Science ®Google Scholar
• Diana M. The dopamine hypothesis of drug addiction and its potential therapeutic value. Front. Psychiatry. 2011;2:64. doi:10.3389/fpsyt.2011.00064.
   PubMedGoogle Scholar
• Pescor MJ. Follow-up study of treated narcotics addicts. Publ Health Rep. 1943;(Suppl 170):1–18.
   PubMedGoogle Scholar
• Vaillant GE. A 20-year follow-up of New York narcotic addicts. Arch Gen Psychiatry. 1973;29(2):237–41. doi:10.1001/archpsyc.1973.04200020065009.
   PubMed Web of Science ®Google Scholar
• Mayet S, Farrell M, Ferri M, Amato L, Davoli M. Psychosocial treatment for opiate abuse and dependence. Cochrane Database Syst Rev. 2005;(1):CD004330.
   PubMed Web of Science ®Google Scholar
• Ayanga D, Shorter D & Kosten T. Update on pharmacotherapy for treatment of opioid use disorder, Expert Opin Pharmacother. 2016;17(17):2307–2318. doi:10.1080/14656566.2016.1244529.
   PubMed Web of Science ®Google Scholar
• Oesterle TS, Thusius NJ, Rummans TA, Gold MS. Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clin Proc. 2019;94(10):2072–2086. doi:10.1016/j.mayocp.2019.03.029.
   PubMed Web of Science ®Google Scholar
• Marsden J, Tai B, Ali R, Hu L, Rush AJ, Volkow N. Measurement-based care using DSM-5 for opioid use disorder: Can we make opioid medication treatment more effective? Addiction. 2019;114(8):1346–1353. doi:10.1111/add.14546.
   PubMed Web of Science ®Google Scholar
• Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend. 2015;150:112–9. doi:10.1016/j.drugalcdep.2015.02.030.
   PubMed Web of Science ®Google Scholar
• Pettorruso M, Giannantonio MD, Risio LD, Martinotti G, Koob GF. A Light in the Darkness: Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat the Hedonic Dysregulation of Addiction. J Addict Med. 2019;1:1–3. doi:10.1097/ADM.0000000000000575.
   Google Scholar
• Volkow ND. Personalizing the Treatment of Substance Use Disorders. Am J Psychiatry. 2020;177(2):113–116. doi:10.1176/appi.ajp.2019.19121284.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Class II Special Controls Guidance Document: Repetitive Transcranial Magnetic Stimulation (rTMS) Systems. 2011.
   Google Scholar
• Goldner EM, Lusted A, Roerecke M, Rehm J, Fischer B. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addict Behav. 2014;39(3):520–531. doi:10.1016/j.addbeh.2013.11.022.
   PubMed Web of Science ®Google Scholar
• Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul. 2016;9(3):336–346. doi:10.1016/j.brs.2016.03.010.
   PubMed Web of Science ®Google Scholar
• Beynel L, Powers JP, Appelbaum LG. Effects of repetitive transcranial magnetic stimulation on resting-state connectivity: A systematic review. Neuroimage. 2020;211:116596 [Epub ahead of print]. doi:10.1016/j.neuroimage.2020.116596.
   PubMed Web of Science ®Google Scholar
• McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, Cook IA, O’Reardon J, Husain MM, Wall C, Krystal AD, Sampson SM, Morales O, Nelson BG, Latoussakis V, George MS, Lisanby SH, National Network of Depression Centers rTMS Task Group; American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. J Clin Psychiat. 2018;79(1).
   Web of Science ®Google Scholar
• Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomized non-inferiority trial. Lancet. 2018;391(10131):1683–1692. doi:10.1016/S0140-6736(18)30295-2.
   PubMed Web of Science ®Google Scholar
• Williams LM. Precision psychiatry: a neural circuit taxonomy for depression and anxiety. Lancet Psychiatry. 2016;3(5):472–480.
   PubMed Web of Science ®Google Scholar
• Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, Ochsner KN. Prefrontal-striatal pathway underlies cognitive regulation of craving. PNAS. 2010;107(33):14811–14816. doi:10.1073/pnas.1007779107.
   PubMed Web of Science ®Google Scholar
• Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, Anderson J, Nutile L, Renshaw P, Weiss R, Becerra L, Borsook D. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010;133(7):2098–2114. doi:10.1093/brain/awq138.
   PubMedGoogle Scholar
• Stewart JL, May AC, Aupperle RL, Bodurka J. Forging Neuroimaging Targets for Recovery in Opioid Use Disorder. Front Psychiatry. 2019;10:117. doi:10.3389/fpsyt.2019.00117.
   PubMed Web of Science ®Google Scholar
• Murphy A, Lubman DI, Mckie S, Bijral, PS, Peters LA, Faiz Q, Holmes SE, Anderson IM, Deakin B, Elliott R. Time-dependent neuronal changes associated with craving in opioid dependence: an fMRI study. Addict Biol. 2018;23(5):1168–1178. doi:10.1111/adb.12554.
   PubMed Web of Science ®Google Scholar
• Katzman M, Sternat T. Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat. 2016;12:2149–2164. doi:10.2147/NDT.S111818.
   PubMed Web of Science ®Google Scholar
• Coles AS, Kozak K, George TP. A review of brain stimulation methods to treat substance use disorders. Am J Addict. 2018;27(2):71–91. doi:10.1111/ajad.12674.
   PubMed Web of Science ®Google Scholar
• Trojak B, Sauvaget A, Fecteau S, Lalanne L, Chauvet-Gelinier JC, Koch S, Bulteau S, Zullino D, Achab S. Outcome of Non-Invasive Brain Stimulation in Substance Use Disorders: A Review of Randomized Sham-Controlled Clinical Trials. J Neuropsychiatry Clin Neurosci.. 2017;29(2):105–118. doi:10.1176/appi.neuropsych.16080147.
   PubMed Web of Science ®Google Scholar
• Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, Castelo-Branco L, Challet-Bouju G, Clark VP, Claus E, Dannon PN, DelFelice A, den Uyl T, Diana M, di Giannantonio M, Fedota JR, Fitzgerald P, Gallimberti L, Grall-Bronnec M, Herremans SC, Herrmann MJ, Jamil A, Khedr E, Kouimtsidis C, Kozak K, Krupitsky E, Lamm C, Lechner WV, Madeo G, Malmir N, Martinotti G,McDonald W, Montemitro C, Nakamura-Palacios EM, Nasehi M, No ¨el X, Nosratabadi M, Paulus M, Pettorruso M, Pradhan B, Praharaj SK, Rafferty H, Sahlem G, jo Salmeron B, Sauvaget A, Schluter RS, Sergiou C, Shahbabaie A, Sheffer C, Spagnolo PA, Steele VR, Yuan T-fei, van Dongen J, Van Waes V, Venkatasubramanian G, Verdejo-Garc ́ıa A,Verveer I, Welsh J, Wesley MJ, Witkiewitz K, Yavari F, Zarrindast M-Reza, Zawertailo L, Zhang X, Cha Y-Hee, George TP, Frohlich F, Goudriaan AE, Fecteau S, Daughters SB, Stein EA, Fregni F, Nitsche MA, Zangen A, Bikson M, Hanlon CA. Transcranial Electrical and Magnetic Stimulation (tES and TMS) for Addiction Medicine: A consensus paper on the present state of the science and the road ahead. Neurosci Biobehav R. 2019;104:118–140. doi:10.1016/j.neubiorev.2019.06.007.
   PubMed Web of Science ®Google Scholar
• Koob GF, Le Moal M. Neurobiology of addiction. London: Elsevier. AP. 2011.
   Google Scholar
• Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC. Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug Alcohol Depend. 2015;151:47–55. doi:10.1016/j.drugalcdep.2015.02.033.
   PubMed Web of Science ®Google Scholar
• Bart G. Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 2012;31(3):207–225. doi:10.1080/10550887.2012.694598.
   PubMed Web of Science ®Google Scholar
• Miranda A & Taca A. Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment. Am J Drug Alcohol Abuse. 2018;44(1):56–63. doi:10.1080/00952990.2017.1295459.
   PubMed Web of Science ®Google Scholar
• Sclocco R, Garcia RG, Kettner NW, Isenburg K, Fisher HP, Hubbard CS, Ay I, Goldstein J, Makris N, Toschi N, Barbieri R, Napadow V. The influence of respiration on brainstem and cardiovagal response to auricular vagus nerve stimulation: A multimodal ultrahigh-field (7T) fMRI study. Brain Stimul. 2019;12(4):911–921. doi:10.1016/j.brs.2019.02.003.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Class II Special Controls Guidance Document: NSS-2 BRIDGE device. 2017.
   Google Scholar
• U.S. Food and Drug Administration. 510(k) Premarket Notification: Drug Relief. DyAnsys Inc. 2018.
   Google Scholar
• Roberts A, Sithole A, Sedghi M, Walker CA, Quinn TM. Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study. Med devices. 2016;9:389–393. doi:10.2147/MDER.S107426.
   Google Scholar
• Sheffer CE, Bickel WK, Brandon TH, Franck CT, Deen D, Panissidi L, Abdali SA, Pittman JC, Lunden SE, Prashad N. Malhotra R, Mantovani A. Preventing relapse to smoking with transcranial magnetic stimulation: feasibility and potential efficacy. Drug Alcohol Depend. 2018;182:8–18 doi:10.1016/j.drugalcdep.2017.09.037.
   PubMed Web of Science ®Google Scholar
• Falcone M, Bernardo L, Ashare RL, Hamilton R, Faseyitan O, Mckee SA, Loughead J, Lerman C. Transcranial direct current brain stimulation increases ability to resist smoking. Brain Stimul. 2016;9:191–196. doi:10.1016/j.brs.2015.10.004.
   PubMed Web of Science ®Google Scholar
• Martinez D, Urban N, Grassetti A, Chang D, Hu MC, Zangen A, Levin FR, Foltin R, Nunes EV. Transcranial magnetic stimulation of medial prefrontal and cingulate cortices reduces cocaine self-administration: a pilot study. Front Psychiatry. 2018;9:10–15.
   PubMed Web of Science ®Google Scholar
• Klauss J, Penido Pinheiro LC, Silva Merlo BL, Correia Santos GDA, Fregni F, Nitsche MA, Miyuki Nakamura-Palacios E. A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence. Int J Neuropsychopharmacol. 2014;17(11):1793–803. doi:10.1017/S1461145714000984.
   PubMed Web of Science ®Google Scholar
• Klauss J, Anders Q, Felippe L, Nitsche M, Nakamura-Palacios E. Multiple sessions of transcranial direct current stimulation (tDCS) reduced craving and relapses for alcohol use: a randomized placebo-controlled trial in alcohol use disorder. Front Pharmacol. 2018;9:1–11.
   PubMed Web of Science ®Google Scholar
• Robinson TE, Berridge KC. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci.. 2008;363(1507):3137–3146. doi:10.1098/rstb.2008.0093.
   PubMed Web of Science ®Google Scholar
• Shen Y, Cao X, Tan T, Shan C, Wang Y, Pan J, He H, Yuan T. 10-Hz Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex Reduces Heroin Cue Craving in Long-Term Addicts. Biol Psychiatry. 2016;80(3). doi:10.1016/j.biopsych.2016.02.006.
   Web of Science ®Google Scholar
• Mahoney JJ, Marshalek PJ, Rezai AR, Lander LR, Berry JH, Haut MW. A case report illustrating the effects of repetitive transcranial magnetic stimulation on cue-induced craving in an individual with opioid and cocaine use disorder. Exp Clin Psychopharm. 2019 Oct 24 [Epub ahead of print]. doi:10.1037/pha0000289.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shen Y, Cao X, Shan C, Pan J, He H, Ma Y, Yuan T. Transcranial direct current stimulation of the frontal-parietal-temporal area attenuates cue-induced craving for heroin. J Psychiatr Res. 2016;79:1–3. doi:10.1016/j.jpsychires.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Taremian F, Nazari S, Moradveisi L, Moloodi R. Transcranial Direct Current Stimulation on Opium Craving, Depression, and Anxiety: A Preliminary Study. J ECT. 2019;35(3):201–206. doi:10.1097/YCT.0000000000000568.
   PubMed Web of Science ®Google Scholar
• Borckardt JJ, Reeves ST, Milliken C, Carter B, Epperson TI, Gunselman RJ, Madan A, Del Schutte H, Demos HA, George MS. Prefrontal versus motor cortex transcranial direct current stimulation (tDCS) effects on post-surgical opioid use. Brain Stimul. 2017;10(6):1096–1101. doi:10.1016/j.brs.2017.09.006.
   PubMed Web of Science ®Google Scholar
• Khedr E, Sharkawy E, Attia A, Osman NI, Sayed Z. Role of transcranial direct current stimulation on reduction of postsurgical opioid consumption and pain in total knee arthroplasty: Double randomized clinical trial. Eur J Pain 2017;21(8):1355–1365. doi:10.1002/ejp.1034.
   PubMed Web of Science ®Google Scholar
• Dubois, PE, Ossemann M, de Fays K, De Bue P, Gourdin M, Jamart J, Vandermeeren Y. Postoperative Analgesic Effect of Transcranial Direct Current Stimulation in Lumbar Spine Surgery: A Randomized Control Trial. Clin. J. Pain. 2013;29(8), 696–701. doi:10.1097/AJP.0b013e31826fb302.
   PubMed Web of Science ®Google Scholar
• DosSantos MF, Martikainen IK, Nascimento TD, Love TM, Deboer MD, Schambra HM, Bikson M, Zubieta JK, Dasilva AF. Building up Analgesia in Humans via the Endogenous μ-Opioid System by Combining Placebo and Active tDCS: A Preliminary Report. PLoS ONE. 2014;9(7). doi:10.1371/journal.pone.0102350.
   PubMed Web of Science ®Google Scholar
• Borckardt JJ, Romagnuolo J, Reeves ST, Madan A, Frohman H, Beam W, George MS. Feasibility, safety, and effectiveness of transcranial direct current stimulation for decreasing post-ERCP pain: a randomized, sham-controlled, pilot study. Gastrointest Endosc. 2011;73(6):1158–1164. doi:10.1016/j.gie.2011.01.050.
   PubMed Web of Science ®Google Scholar
• Nguyen JP, Dixneuf V, Esnaut J, Moreno A, Malineau C, Nizard J, Lefaucheur J. The Value of High-Frequency Repetitive Transcranial Magnetic Stimulation of the Motor Cortex to Treat Central Pain Sensitization Associated With Knee Osteoarthritis. Front Neurosci. 2019;13:388.
   PubMedGoogle Scholar
• Taylor JJ, Borckardt JJ, George MS. Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia. Pain. 2012;153(6):1219–1225. doi:10.1016/j.pain.2012.02.030.
   PubMed Web of Science ®Google Scholar
• Lamusuo S, Hirvonen J, Lindholm P, Martikainen IK, Hagelberg N, Parkkola R, Taiminen T, Hietala J, Helin S, Virtanen A, Pertovaara A, Jääskeläinen SK. Neurotransmitters behind pain relief with transcranial magnetic stimulation – positron emission tomography evidence for release of endogenous opioids. Eur J Pain 2017;21(9):1505–1515. doi:10.1002/ejp.1052.
   PubMed Web of Science ®Google Scholar
• Dobek CE, Blumberger DM, Downar J, Daskalakis ZJ, Vila-Rodriguez F. Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion. Neuropsychiatr Dis Treat.. 2015;11:2975–2987.
   PubMed Web of Science ®Google Scholar
• Mishra BR, Nizamie SH, Das B, Praharaj SK. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction. 2010;105(1):49–55. doi:10.1111/j.1360-0443.2009.02777.x.
   PubMed Web of Science ®Google Scholar
• Amad A, Jardri R, Rousseau C, Larochelle Y, Ioannidis JP, Naudet, F. Excess significance bias in repetitive transcranial magnetic stimulation literature for neuropsychiatric disorders. Psychother Psychosom. 2019;7:1–8. doi:10.1159/000502805.
   Google Scholar